Case Report
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2025; 13(9): 96897
Published online Mar 26, 2025. doi: 10.12998/wjcc.v13.i9.96897
Pulmonary artery stent thrombosis and symptomatic pulmonary hypertension following COVID-19 infection in Alagille patient: A case report
Shimon Izhakian, Miriam Korlansky, Dror Rosengarten, Elchanan Bruckheimer, Mordechai Reuven Kramer
Shimon Izhakian, Miriam Korlansky, Dror Rosengarten, Mordechai Reuven Kramer, Pulmonary Institute, Rabin Medical Center, Petach Tikva 49100, Israel
Elchanan Bruckheimer, Cardiac Catheterization Laboratory, Schneider Children's Medical Center, Petach Tikva 49100, Israel
Co-first authors: Shimon Izhakian and Miriam Korlansky.
Author contributions: Izhakian S and Korlansky M contributed equally to the acquisition and interpretation of the data; Izhakian S and Korlansky M contributed equally to the critical revision of the manuscript for important intellectual content; Izhakian S, Korlansky M, Rosengarten D, Bruckheimer E and Kramer MR contributed to the drafting of the manuscript and approved the final version.
Informed consent statement: Written informed consent was obtained from the patient for publication of this manuscript and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest related to this work.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shimon Izhakian, MD, PhD, Doctor, Senior Lecturer, Pulmonary Institute, Rabin Medical Center, 39 Jabotinski St., Petach Tikva 49100, Israel. shimixyz@gmail.com
Received: May 17, 2024
Revised: October 8, 2024
Accepted: December 2, 2024
Published online: March 26, 2025
Processing time: 208 Days and 20.6 Hours
Core Tip

Core Tip: We suggest that in this era of coronavirus disease 2019, patients with endovascular stents and known pulmonary vessel malformations be considered for preventive anticoagulation or antiplatelet therapy, since a thrombotic event in such patients may result in secondary pulmonary hypertension and devastating, irreversible damage. Furthermore, patients with thrombosed stents should be treated aggressively and quickly once a clot is diagnosed.